Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$884M |
| 2 |
Tesla
TSLA
|
+$641M |
| 3 |
Visa
V
|
+$520M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$907M |
| 4 |
Microsoft
MSFT
|
+$832M |
| 5 |
Privia Health
PRVA
|
+$655M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.24% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 8.04% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
Finance of America Companies
FOA
$203M
| $119K | ﹤0.01% |
6,237
+4,467
| +252% | +$74.9K |
|
5202
AlTi Global
ALTI
$399M
| $118K | ﹤0.01% |
+15,374
| New | +$108K |
|
5203
Pyxis Oncology
PYXS
$168M
| $118K | ﹤0.01% |
45,974
+10,550
| +30% | +$33.5K |
|
5204
USCB Financial Holdings
USCB
$406M
| $117K | ﹤0.01% |
+11,512
| New | +$113K |
|
5205
Capricor Therapeutics
CAPR
$223M
| $117K | ﹤0.01% |
24,549
-75
| -0.3% | -$330 |
|
|
IMA
5206
ImageneBio Inc
IMA
$63M
| $116K | ﹤0.01% |
1,479
-1,454
| -50% | -$104K |
|
|
BRFS
5207
DELISTED
BRF SA
BRFS
| $116K | ﹤0.01% |
61,226
-2,469,726
| -98% | -$3.81M |
|
5208
NLI Holdings
NL
$281M
| $115K | ﹤0.01% |
20,762
-5,314
| -20% | -$31.6K |
|
5209
Skillsoft
SKIL
$63.7M
| $115K | ﹤0.01% |
4,619
+918
| +25% | +$26.8K |
|
5210
First Northwest Bancorp
FNWB
$109M
| $114K | ﹤0.01% |
10,049
-33
| -0.3% | -$377 |
|
5211
Bakkt Inc
BKKT
$321M
| $114K | ﹤0.01% |
3,710
+803
| +28% | +$28.1K |
|
|
CELL
5212
DELISTED
PhenomeX Inc. Common Stock
CELL
| $114K | ﹤0.01% |
232,070
+30,288
| +15% | +$24.8K |
|
5213
Viant Technology
DSP
$236M
| $111K | ﹤0.01% |
23,984
-7,738
| -24% | -$34.3K |
|
5214
Veru
VERU
$36M
| $110K | ﹤0.01% |
9,251
-187
| -2% | -$2.19K |
|
5215
Goldgroup Mining Inc.
GORO
$157M
| $109K | ﹤0.01% |
172,619
+39,504
| +30% | +$35K |
|
5216
Ondas Inc
ONDS
$4.27B
| $107K | ﹤0.01% |
124,843
+79,877
| +178% | +$76K |
|
5217
Aveanna Healthcare
AVAH
$2.04B
| $107K | ﹤0.01% |
63,476
-3,649,853
| -98% | -$4.58M |
|
5218
VistaGen Therapeutics
VTGN
$9.89M
| $107K | ﹤0.01% |
57,316
+54,060
| +1,660% | +$189K |
|
5219
Foghorn Therapeutics
FHTX
$266M
| $107K | ﹤0.01% |
15,217
-15,858
| -51% | -$111K |
|
5220
Prelude Therapeutics
PRLD
$366M
| $107K | ﹤0.01% |
23,788
-25,708
| -52% | -$154K |
|
5221
AtaiBeckley Inc
ATAI
$2.66B
| $107K | ﹤0.01% |
62,093
-35,158
| -36% | -$64.7K |
|
|
PLM
5222
DELISTED
PolyMet Mining Corp.
PLM
| $105K | ﹤0.01% |
133,184
+65,846
| +98% | +$98.8K |
|
5223
Actinium Pharmaceuticals
ATNM
$26.3M
| $103K | ﹤0.01% |
13,939
-79,176
| -85% | -$674K |
|
5224
ECARX Holdings
ECX
$417M
| $102K | ﹤0.01% |
+14,726
| New | +$93K |
|
|
APPH
5225
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $102K | ﹤0.01% |
276,352
+198,766
| +256% | +$89.8K |
|
Similar funds
Goldman Sachs's Q2 2023 Portfolio in Review
As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q2 2023 filing shows 443 new, 2,419 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
- Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
- Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
- Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
- Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
- Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
- Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.